A detailed history of Rothschild & CO Asset Management Us Inc. transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Rothschild & CO Asset Management Us Inc. holds 666,214 shares of FOLD stock, worth $7.65 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
666,214
Previous 713,946 6.69%
Holding current value
$7.65 Million
Previous $7.45 Million 9.12%
% of portfolio
0.12%
Previous 0.13%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$9.89 - $12.7 $472,069 - $606,196
-47,732 Reduced 6.69%
666,214 $8.13 Million
Q3 2022

Nov 07, 2022

SELL
$9.82 - $12.75 $1.56 Million - $2.02 Million
-158,654 Reduced 18.18%
713,946 $7.45 Million
Q2 2022

Aug 09, 2022

SELL
$6.23 - $11.12 $261,753 - $467,206
-42,015 Reduced 4.59%
872,600 $9.37 Million
Q1 2022

May 13, 2022

SELL
$7.89 - $12.48 $2.36 Million - $3.74 Million
-299,502 Reduced 24.67%
914,615 $8.66 Million
Q4 2021

Feb 11, 2022

SELL
$9.82 - $12.44 $461,991 - $585,252
-47,046 Reduced 3.73%
1,214,117 $14 Million
Q3 2021

Nov 09, 2021

SELL
$8.74 - $11.84 $1.28 Million - $1.74 Million
-146,768 Reduced 10.42%
1,261,163 $12 Million
Q2 2021

Aug 16, 2021

BUY
$8.71 - $10.72 $2.28 Million - $2.81 Million
262,337 Added 22.9%
1,407,931 $13.6 Million
Q1 2021

May 14, 2021

SELL
$9.2 - $23.86 $3.1 Million - $8.04 Million
-336,873 Reduced 22.72%
1,145,594 $11.3 Million
Q4 2020

Feb 08, 2021

SELL
$13.47 - $24.89 $3.79 Million - $7 Million
-281,263 Reduced 15.95%
1,482,467 $34.2 Million
Q3 2020

Nov 09, 2020

BUY
$12.89 - $15.89 $248,428 - $306,247
19,273 Added 1.1%
1,763,730 $24.9 Million
Q2 2020

Aug 10, 2020

SELL
$8.86 - $15.69 $2.56 Million - $4.53 Million
-288,663 Reduced 14.2%
1,744,457 $26.3 Million
Q1 2020

May 14, 2020

SELL
$6.63 - $11.16 $1.11 Million - $1.87 Million
-167,787 Reduced 7.62%
2,033,120 $18.8 Million
Q4 2019

Feb 12, 2020

BUY
$7.48 - $10.75 $5.11 Million - $7.34 Million
682,567 Added 44.95%
2,200,907 $21.4 Million
Q3 2019

Nov 08, 2019

SELL
$8.02 - $13.25 $128,985 - $213,099
-16,083 Reduced 1.05%
1,518,340 $12.2 Million
Q2 2019

Jul 25, 2019

BUY
$10.96 - $14.4 $476,573 - $626,155
43,483 Added 2.92%
1,534,423 $19.2 Million
Q1 2019

May 08, 2019

SELL
$10.04 - $13.92 $305,205 - $423,154
-30,399 Reduced 2.0%
1,490,940 $20.3 Million
Q4 2018

Feb 05, 2019

BUY
$8.38 - $13.44 $181,452 - $291,016
21,653 Added 1.44%
1,521,339 $14.6 Million
Q3 2018

Nov 13, 2018

BUY
$11.6 - $16.54 $14.7 Million - $20.9 Million
1,264,173 Added 536.77%
1,499,686 $18.1 Million
Q2 2018

Aug 07, 2018

BUY
$13.13 - $17.09 $1.83 Million - $2.38 Million
139,382 Added 144.99%
235,513 $3.68 Million
Q1 2018

May 08, 2018

BUY
$13.76 - $17.12 $49,838 - $62,008
3,622 Added 3.92%
96,131 $1.45 Million
Q4 2017

Feb 12, 2018

BUY
$12.51 - $16.24 $1.16 Million - $1.5 Million
92,509
92,509 $1.33 Million

Others Institutions Holding FOLD

About AMICUS THERAPEUTICS, INC.


  • Ticker FOLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 280,497,984
  • Market Cap $3.22B
  • Description
  • Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...
More about FOLD
Track This Portfolio

Track Rothschild & CO Asset Management Us Inc. Portfolio

Follow Rothschild & CO Asset Management Us Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rothschild & CO Asset Management Us Inc., based on Form 13F filings with the SEC.

News

Stay updated on Rothschild & CO Asset Management Us Inc. with notifications on news.